165 related articles for article (PubMed ID: 29297704)
21. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
[TBL] [Abstract][Full Text] [Related]
22. A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.
Luo D; Deng B; Weng M; Luo Z; Nie X
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1207-1214. PubMed ID: 28835135
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
24. Development of six immune-related lncRNA signature prognostic model for smoking-positive lung adenocarcinoma.
Zhou D; Wang J; Liu X
J Clin Lab Anal; 2022 Jun; 36(6):e24467. PubMed ID: 35561270
[TBL] [Abstract][Full Text] [Related]
25. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
26. An exosomes-related lncRNA prognostic model correlates with the immune microenvironment and therapy response in lung adenocarcinoma.
Chu D; Chen L; Li W; Zhang H
Clin Exp Med; 2024 May; 24(1):104. PubMed ID: 38761234
[TBL] [Abstract][Full Text] [Related]
27. Low expression of LINC00982 and PRDM16 is associated with altered gene expression, damaged pathways and poor survival in lung adenocarcinoma.
Lv W; Yu X; Li W; Feng N; Feng T; Wang Y; Lin H; Qian B
Oncol Rep; 2018 Nov; 40(5):2698-2709. PubMed ID: 30132554
[TBL] [Abstract][Full Text] [Related]
28. Survival analysis and functional annotation of long non-coding RNAs in lung adenocarcinoma.
Salavaty A; Rezvani Z; Najafi A
J Cell Mol Med; 2019 Aug; 23(8):5600-5617. PubMed ID: 31211495
[TBL] [Abstract][Full Text] [Related]
29. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
31. Detection and Analysis of Wnt Pathway Related lncRNAs Expression Profile in Lung Adenocarcinoma.
Chen J; Hu L; Chen J; Pan Q; Ding H; Xu G; Zhu P; Wen X; Huang K; Wang Y
Pathol Oncol Res; 2016 Jul; 22(3):609-15. PubMed ID: 26857641
[TBL] [Abstract][Full Text] [Related]
32. Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma.
Zhang J; Bai S; Yan Y; Kang H; Li G; Feng Z; Ma W; Wang X; Ren J
BMC Pulm Med; 2023 Aug; 23(1):284. PubMed ID: 37537521
[TBL] [Abstract][Full Text] [Related]
33. A Novel Long Non-Coding RNA, SOX21-AS1, Indicates a Poor Prognosis and Promotes Lung Adenocarcinoma Proliferation.
Lu X; Huang C; He X; Liu X; Ji J; Zhang E; Wang W; Guo R
Cell Physiol Biochem; 2017; 42(5):1857-1869. PubMed ID: 28873379
[TBL] [Abstract][Full Text] [Related]
34. Construction and validation of a prognostic signature based on anoikis-related lncRNAs in lung adenocarcinoma.
Dong X; Shao C; Xu S; Tu J; Xu W; Chen D; Tang Y
Aging (Albany NY); 2024 Jun; 16(11):9899-9917. PubMed ID: 38850527
[TBL] [Abstract][Full Text] [Related]
35. An eight-long non-coding RNA signature as a candidate prognostic biomarker for lung cancer.
Tu Z; He D; Deng X; Xiong M; Huang X; Li X; Hao L; Ding Q; Zhang Q
Oncol Rep; 2016 Jul; 36(1):215-22. PubMed ID: 27222340
[TBL] [Abstract][Full Text] [Related]
36. Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615.
Shan Y; Xia T; Xie W; Wan W; Wu N; Yuan Z; Hu Q; Chen Z; Li C; Wu L; Wu W; Cai T; Xiang Y; Bai L; Li Y
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17781-17793. PubMed ID: 37934255
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma.
Zhou Q; Xiong J; Gao Y; Yi R; Xu Y; Chen Q; Wang L; Chen Y
Funct Integr Genomics; 2023 Oct; 23(4):323. PubMed ID: 37864709
[TBL] [Abstract][Full Text] [Related]
38. Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma.
Wu Y; Wei J; Ming Y; Chen Z; Yu J; Mao R; Chen H; Zhou G; Fan Y
J Cell Biochem; 2018 Sep; 119(9):7696-7706. PubMed ID: 29923223
[TBL] [Abstract][Full Text] [Related]
39. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma.
Li X; Shi Y; Yin Z; Xue X; Zhou B
J Transl Med; 2014 Jun; 12():159. PubMed ID: 24893932
[TBL] [Abstract][Full Text] [Related]
40. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
